We serve Chemical Name:1-[4-[3-(4-fluorophenoxy)phenyl]but-3-yn-2-yl]-1-hydroxyurea CAS:141579-54-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![1-[4-[3-(4-fluorophenoxy)phenyl]but-3-yn-2-yl]-1-hydroxyurea](https://a.dearchem.com/CAS2/141579-54-6.png)
Chemical Name:1-[4-[3-(4-fluorophenoxy)phenyl]but-3-yn-2-yl]-1-hydroxyurea
CAS.NO:141579-54-6
Synonyms:Fenleuton;N-hydroxy-N-[4-(3-(4-fluorophenoxy)-phenyl)-3-butyn-2-yl]urea;Urea,N-[3-[3-(4-fluorophenoxy)phenyl]-1-methyl-2-propyn-1-yl]-N-hydroxy;Lofrin (TN);Fenleuton (USAN/INN);1-{4-[3-(4-fluorophenoxy)phenyl]but-3-yn-2-yl}-1-hydroxyurea
Molecular Formula:C17H15FN2O3
Molecular Weight:314.31100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:489.5ºC at 760mmHg
Density:1.36g/cm3
Index of Refraction:1.643
PSA:76.78000
Exact Mass:314.10700
LogP:3.64170
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Fenleuton chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-{4-[3-(4-fluorophenoxy)phenyl]but-3-yn-2-yl}-1-hydroxyurea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fenleuton (USAN/INN) Use and application,Fenleuton technical grade,usp/ep/jp grade.
Related News: However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. ethyl 4-(2-hydroxyethyl)piperazine-1-carboxylate manufacturers After recently opening one cell therapy plant and breaking ground on another in Massachusetts, Takeda is pivoting westward to beef up production in California. 2-[(4-hydroxypiperidin-1-yl)methyl]benzenecarboximidamide suppliers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. Hexadecanamide, N-[(1R,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-(1-pyrrolidinylmethyl)ethyl] vendor & factory.
